Changes in Bad phosphorylation are correlated with BCR-induced apoptosis of WEHI-231 immature B cells

被引:12
|
作者
Malissein, E [1 ]
Verdier, M [1 ]
Ratinaud, MH [1 ]
Troutaud, D [1 ]
机构
[1] Fac Med Limoges, UMR CNRS 6101, Lab Physiol Mol Mitochondriale & Immunitaire, F-87025 Limoges, France
关键词
apoptosis; mitochondria; Bad phosphorylation; immature B cells; BCR;
D O I
10.1016/S0300-9084(03)00140-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Signaling through the B cell antigen receptor (BCR) is a key determinant in the regulation of B cell physiology. Depending on additional factors, such as microenvironment and developmental stage, ligation of the BCR can trigger B lymphocyte activation, proliferation, or apoptosis. The regulatory mechanisms determining B cell apoptosis and survival are not completely known. Using the murine B lymphoma cell line WEHI-231 as a model system, we investigated the role of Bad phosphorylation, a pro-apoptotic member of the Bcl-2 family, in anti-IgM mediated apoptosis. For apoptotic analysis we focused in particular on the mitochondrial potential (DeltaPsi(m)) collapse which has been reported as a rate-limiting step in the BCR-induced cell death of immature B lymphocytes. Bad phosphorylation at serine 112, 136 and 155 was found in WEHI-231 cell control cultures and its hypophosphorylation on the three sites correlated with the appearance of apoptosis when cross-linking surface IgM. Furthermore, treatment of cells with specific PK inhibitors known to be involved in serine phosphorylation of Bad (LY294002 for PI3K and H-89 for PKA) mimiced or enhanced BCR-induced cell death. These results strongly suggest that regulation of Bad phosphorylation plays an active role in mediating anti-IgM-induced apoptosis of immature B cells. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:733 / 740
页数:8
相关论文
共 50 条
  • [31] Evidence for unique calmodulin-dependent nuclear factor-κB regulation in WEHI-231 B cells
    Shumway, SD
    Berchtold, CM
    Gould, MN
    Miyamoto, S
    MOLECULAR PHARMACOLOGY, 2002, 61 (01) : 177 - 185
  • [32] MEMBRANE REGION OF SURFACE IGM IS NOT SUFFICIENT FOR TRANSDUCING GROWTH INHIBITORY SIGNALS IN AN IMMATURE B-CELL LINE WEHI-231
    IWABUCHI, N
    WILLIAMS, DB
    NGUYEN, HP
    WU, YJ
    TISCH, R
    AZUMA, T
    PHILLIPS, MJ
    HOZUMI, N
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (10) : 2507 - 2511
  • [33] Unmethylated CpG-containing oligodeoxynucleotides inhibit apoptosis in WEHI-231 B lymphocytes induced by several agents: evidence for blockade of apoptosis at a distal signalling step
    Macfarlane, DE
    Manzel, L
    Krieg, AM
    IMMUNOLOGY, 1997, 91 (04) : 586 - 593
  • [34] INHIBITION OF NF-KAPPA-B/REL BINDING REDUCES EXPRESSION OF C-MYC AND INDUCES APOPTOSIS OF WEHI-231 B-CELLS
    WU, M
    ARSURA, M
    SCHAUER, S
    LEE, H
    SONENSHEIN, GE
    MOLECULAR BIOLOGY OF THE CELL, 1995, 6 : 2066 - 2066
  • [35] Requirement for BTG/TOB family protein in anti-IgM-induced growth arrest of WEHI-231 B lymphoma cells
    Mizuguchi, J
    Hata, K
    FASEB JOURNAL, 2005, 19 (04): : A953 - A953
  • [36] THE ROLE OF BCL-X(L) IN CD40-MEDIATED RESCUE FROM ANTI-MU-INDUCED APOPTOSIS IN WEHI-231 B-LYMPHOMA-CELLS
    CHOI, MSK
    BOISE, LH
    GOTTSCHALK, AR
    QUINTANS, J
    THOMPSON, CB
    KLAUS, GGB
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (05) : 1352 - 1357
  • [37] Engagement of membrane immunoglobulin enhances Id3 promoter activity in WEHI-231 B lymphoma cells
    Xiao-jun Li
    Kikumi Hata
    Junichiro Mizuguchi
    Acta Pharmacologica Sinica, 2005, 26 : 486 - 491
  • [38] Engagement of membrane immunoglobulin enhances Id3 promoter activity in WEHI-231 B lymphoma cells
    Li, XJ
    Hata, K
    Mizuguchi, J
    ACTA PHARMACOLOGICA SINICA, 2005, 26 (04) : 486 - 491
  • [39] CD40 and sIg receptor cross-talk at the levels of CREB/ATF and rescue of WEHI-231 B cells from apoptosis.
    Wang, Z
    Karras, JG
    Xie, H
    Rothstein, TL
    BLOOD, 1995, 86 (10) : 1260 - 1260
  • [40] Engagement of membrane immunoglobulin enhances Id3 promoter activity in WEHI-231 B lymphoma cells
    Kikumi HATA
    Junichiro MIZUGUCHI
    Acta Pharmacologica Sinica, 2005, (04) : 486 - 491